Showing results (51-60 of 164) with videos related to

Sort By:
Pageof 17
Haematologica|December 23, 2020
Targeting MCL-1 dysregulates cell metabolism and leukemia-stroma interactions and resensitizes acute myeloid leukemia to BCL-2 inhibitionBing Z Carter, Po Yee Mak, Wenjing Tao, et al.
Molecular & Cellular Proteomics : MCP|February 1, 2026
High-throughput proteomic profiling to evaluate differentiation syndrome with menin inhibitionMiriam B Garcia, Bofei Wang, Irtiza Sheikh, et al.
Neoplasia (New York, N.Y.)|April 11, 2022
Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2/CCR2 signaling interactions with MET receptor tyrosine kinasesDiana Sofía Acevedo, Wei Bin Fang, Vinamratha Rao, et al.
Research Square|February 14, 2024
An IROA Workflow for correction and normalization of ion suppression in mass spectrometry-based metabolomic profiling dataIqbal Mahmud, Bo Wei, Lucas Veillon, et al.
The Journal of Biological Chemistry|August 23, 2023
The transcription factor ChREBP links mitochondrial lipidomes to mitochondrial morphology and progression of diabetic kidney diseaseLi Li, Jianyin Long, Koki Mise, et al.
Journal of Lipid Research|August 25, 2024
Mechanistic insights into metabolic function of dynamin-related protein 1Xin Li, Katherine Pham, Jazmin Ysaguirre, et al.
Cell Reports|August 11, 2021
PGC1α is required for the renoprotective effect of lncRNA Tug1 in vivo and links Tug1 with urea cycle metabolitesLi Li, Jianyin Long, Koki Mise, et al.
Cell Metabolism|February 7, 2024
Itaconate impairs immune control of Plasmodium by enhancing mtDNA-mediated PD-L1 expression in monocyte-derived dendritic cellsTheresa Ramalho, Patricia A Assis, Ogooluwa Ojelabi, et al.
Cancer & Metabolism|February 23, 2022
Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomasEvelyn de Groot, Sruthy Varghese, Lin Tan, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 20, 2005
Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivoPhilip L Lorenzi, Christopher P Landowski, Xueqin Song, et al.
Pageof 17